<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In addition, the oil showed remarkable antioxidant activity as judged by 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity assay, ferric reducing/antioxidant power (FRAP) assay, superoxide anion radical scavenging activity assay, and metal-chelating activity assay [
 <xref rid="B50-nutrients-10-01196" ref-type="bibr" class="xref">50</xref>,
 <xref rid="B74-nutrients-10-01196" ref-type="bibr" class="xref">74</xref>,
 <xref rid="B168-nutrients-10-01196" ref-type="bibr" class="xref">168</xref>,
 <xref rid="B169-nutrients-10-01196" ref-type="bibr" class="xref">169</xref>]. Turmeric EO prevented oxidative stress in 
 <italic class="italic">Brycon amazonicus</italic> via reducing the synthesis or release of cortisol and increasing the activity of antioxidant enzymes, and thereby protecting from the formation of reactive oxygen species excess [
 <xref rid="B23-nutrients-10-01196" ref-type="bibr" class="xref">23</xref>,
 <xref rid="B67-nutrients-10-01196" ref-type="bibr" class="xref">67</xref>,
 <xref rid="B96-nutrients-10-01196" ref-type="bibr" class="xref">96</xref>]. The potent antioxidant activity of turmeric EO is thought to be responsible for inhibiting brain-edema formation, one of the most dangerous consequences of ischemic brain injury [
 <xref rid="B170-nutrients-10-01196" ref-type="bibr" class="xref">170</xref>]. Treatment with turmeric EO reduced nitric oxide production derived by inducible nitric oxide synthase (iNOS) during ischemic injury [
 <xref rid="B231-nutrients-10-01196" ref-type="bibr" class="xref">231</xref>]. Turmeric EO inhibited copper-mediated oxidation of LDL in the thiobarbituric acid reactive substances assay (IC
 <sub class="sub">50</sub> = 7.8 ± 0.2 µg/mL) [
 <xref rid="B71-nutrients-10-01196" ref-type="bibr" class="xref">71</xref>]. Turmeric EO (250–500 mg/kg p.o. or i.p.) showed neuroprotective effects in rat embolic-stroke model [
 <xref rid="B170-nutrients-10-01196" ref-type="bibr" class="xref">170</xref>,
 <xref rid="B171-nutrients-10-01196" ref-type="bibr" class="xref">171</xref>]. In filament model of middle cerebral-artery occlusion, pretreatment with turmeric EO showed a neuroprotective effect by inhibiting the generation of free radicals [
 <xref rid="B170-nutrients-10-01196" ref-type="bibr" class="xref">170</xref>,
 <xref rid="B171-nutrients-10-01196" ref-type="bibr" class="xref">171</xref>]. Its neuroprotective efficacy was mediated by reducing endothelial cell-mediated inflammation in postmyocardial ischemia/reperfusion in rats [
 <xref rid="B166-nutrients-10-01196" ref-type="bibr" class="xref">166</xref>,
 <xref rid="B172-nutrients-10-01196" ref-type="bibr" class="xref">172</xref>]. It was also suggested that the ability of the oil to access the brain after stroke was via the transcellular lipophilic pathway [
 <xref rid="B170-nutrients-10-01196" ref-type="bibr" class="xref">170</xref>]. Turmeric EO (500 mg/kg, p.o.) was an efficacious and safe antiplatelet agent [
 <xref rid="B174-nutrients-10-01196" ref-type="bibr" class="xref">174</xref>] and was protective against intravascular thrombosis in myocardial ischemia-reperfusion and thrombosis rat models [
 <xref rid="B172-nutrients-10-01196" ref-type="bibr" class="xref">172</xref>,
 <xref rid="B173-nutrients-10-01196" ref-type="bibr" class="xref">173</xref>]. Turmeric oil was effective in treating some respiratory disorders by preventing asthma, removing sputum, and relieving cough [
 <xref rid="B232-nutrients-10-01196" ref-type="bibr" class="xref">232</xref>]. The oil was reported to have anticancer and anti-inflammatory effects [
 <xref rid="B176-nutrients-10-01196" ref-type="bibr" class="xref">176</xref>,
 <xref rid="B178-nutrients-10-01196" ref-type="bibr" class="xref">178</xref>]. It was active against human mouth epidermal carcinoma (KB) cells and mouse leukemia (P388) cells, with respective IC
 <sub class="sub">50</sub> values of 1.088 and 0.084 mg/mL [
 <xref rid="B177-nutrients-10-01196" ref-type="bibr" class="xref">177</xref>]. It was also cytotoxic to the pancreatic cancer (PANC-1), melanoma (B16), prostate cancer (LNCaP), and human cervical adenocarcinoma (HeLa) cell lines due to the presence of 
 <italic class="italic">ar</italic>-turmerone, α-turmerone, β-turmerone, curlone, 
 <italic class="italic">ar</italic>-curcumene, zingiberene, and β-sesquiphellandrene [
 <xref rid="B23-nutrients-10-01196" ref-type="bibr" class="xref">23</xref>,
 <xref rid="B74-nutrients-10-01196" ref-type="bibr" class="xref">74</xref>,
 <xref rid="B175-nutrients-10-01196" ref-type="bibr" class="xref">175</xref>,
 <xref rid="B176-nutrients-10-01196" ref-type="bibr" class="xref">176</xref>]. Crude organic extracts of turmeric-inhibited lipopolysaccharide (LPS)-induced production of tumor necrosis factor (TNF)-α (IC
 <sub class="sub">50</sub> = 15.2 μg/mL) and prostaglandin E2 (PGE2; IC
 <sub class="sub">50</sub> = 0.92μg/mL) in human leukemia (HL-60) cells [
 <xref rid="B181-nutrients-10-01196" ref-type="bibr" class="xref">181</xref>]. In combination with curcumin, turmerones from turmeric EO abolished inflammation-associated mouse-colon carcinogenesis [
 <xref rid="B233-nutrients-10-01196" ref-type="bibr" class="xref">233</xref>]. Turmeric EO demonstrated strong protective effect against benzo[a]pyrene-induced increase in micronuclei in circulating lymphocytes and protected against cytogenetic damage in patients suffering from oral submucous fibrosis, a precancerous condition for oral cancer [
 <xref rid="B179-nutrients-10-01196" ref-type="bibr" class="xref">179</xref>,
 <xref rid="B180-nutrients-10-01196" ref-type="bibr" class="xref">180</xref>].
</p>
